<i>Porphyromonas gingivalis</i> in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors

2019 Science Advances 1,672 citations

Abstract

Gingipains from Porphyromonas gingivalis drive Alzheimer’s pathology and can be blocked with small-molecule inhibitors.

Keywords

Porphyromonas gingivalisDiseaseAlzheimer's diseaseCausationMedicineBiologyNeurosciencePathologyInternal medicinePeriodontitisPhilosophy

MeSH Terms

AgedAlzheimer DiseaseAmyloid beta-PeptidesAnimalsBacteroidaceae InfectionsBrainCell LineTumorDisease ModelsAnimalFemaleGingipain Cysteine EndopeptidasesHumansMaleMiceMiceInbred BALB CMiddle AgedNeuroprotective AgentsPeptide FragmentsPilot ProjectsPorphyromonas gingivalisProspective StudiesSalivaSmall Molecule Librariestau Proteins

Affiliated Institutions

Related Publications

Publication Info

Year
2019
Type
article
Volume
5
Issue
1
Pages
eaau3333-eaau3333
Citations
1672
Access
Closed

Citation Metrics

1672
OpenAlex
54
Influential
1550
CrossRef

Cite This

Stephen S. Dominy, Casey Lynch, Florian Ermini et al. (2019). <i>Porphyromonas gingivalis</i> in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Science Advances , 5 (1) , eaau3333-eaau3333. https://doi.org/10.1126/sciadv.aau3333

Identifiers

DOI
10.1126/sciadv.aau3333
PMID
30746447
PMCID
PMC6357742

Data Quality

Data completeness: 90%